Literature DB >> 2842971

Expression of varicella-zoster virus glycoprotein I in cells infected with a vaccinia virus recombinant.

G Cabirac1, D Gilden, M Wellish, A Vafai.   

Abstract

BSC-1 cells infected with a vaccinia virus recombinant containing the coding sequences for varicella-zoster virus (VZV) glycoprotein I (gpI) were analyzed by indirect immunofluorescence and immunoprecipitation for the expression and processing of gpI. The processing of gpI in cells infected with recombinant virus was the same as that observed during VZV infection. Immunofluorescence revealed localization of gpI to the membranes of recombinant virus-infected cells.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2842971     DOI： 10.1016/0168-1702(88)90016-0

Source DB:  PubMed          Journal:  Virus Res        ISSN： 0168-1702            Impact factor:   3.303


  3 in total

1.  The glycoprotein products of varicella-zoster virus gene 14 and their defective accumulation in a vaccine strain (Oka).

Authors:  P R Kinchington; P Ling; M Pensiero; B Moss; W T Ruyechan; J Hay
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

2.  Neutralizing antibodies induced by recombinant vaccinia virus expressing varicella-zoster virus gpIV.

Authors:  A Vafai; W N Yang
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

3.  Specific lysis of targets expressing varicella-zoster virus gpI or gpIV by CD4+ human T-cell clones.

Authors:  Z Huang; A Vafai; J Lee; R Mahalingam; A R Hayward
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.